At the onset of the COVID-19 crisis, CHOC’s Medical Innovation and Intelligence Institute summer internship prorgram made a quick virtual pivot.
Study determines that Pain Buddy app may aid in reduction of pain severity
A new app may help reduce pain severity in children during cancer treatment, a recently published pilot study finds.
Clinical trials continue the advancement of pediatric oncology treatment
CHOC currently offers more than 140 clinical trials in varying phases, including multiple pharmaceutical industry-sponsored clinical trials.
Investigational Drug Study Leads to FDA Approval for Fenfluramine in Treatment for Dravet Syndrome
Dr. Mary Zupanc was a key investigator in a study that led to FDA approval for a medication to treat children with Dravet syndrome.
CHOC rare disease expert stresses importance of newborn screening
CHOC is one of the state’s largest referral centers for the newborn screening program, which checks babies for many serious genetic disorders.
Leading-edge biomarker research aids in infantile spasms management
Much of infantile spasms research focuses on visual analysis of a patient’s EEG, whereas Dr. Daniel Shrey’s research uses a computation.
